The submission of scientific evidence is essential to support the regulation of cannabis cultivation in Brazil and complies with STJ's determination

New legislation, in effect since December 2025, replaces the 1976 law and aims to enhance the commercial viability of cultivation

The historic investment from the Financier of Studies and Projects (Finep) will finance cutting-edge structures in two regions of the country. The approval, combined with recent authorizations from Anvisa, boosts the development of the scientific bases of the "CBD Brazil" project with the central goal of reducing the costs of medicinal products in Brazil, subsidizing the national production chain

Doctor Beatriz Milani explains how the principle “Start low, go slow” guides the safe and personalized use of medical cannabis, ensuring careful adjustments and the lowest effective dose for each patient

Public call aims to gather scientific evidence to support the regulation of Cannabis cultivation for medicinal and pharmaceutical purposes in Brazil

The collaboration between a marketplace and an association connects doctors and patients to therapies with in natura cannabis flowers produced in Brazil

The collaboration between a marketplace and an association connects doctors and patients to therapies with in natura cannabis flowers produced in Brazil

New research reviews evidence and challenges the idea that the brain only fully matures at 25; experts advocate for information and dialogue on responsible use, especially in adolescence

The detection time varies from days to over a month, depending on frequency of use, metabolism, and the type of test conducted

Document presents preliminary guidelines for authorization of cultivation by legal entities and control mechanisms

Discover what the male flower in cannabis is, why it appears, and how to prevent it from compromising your harvest

Discover what the male flower in cannabis is, why it appears, and how to prevent it from compromising your harvest

Unesp researchers reveal the obstacles that hinder cannabis research in Brazil and point out ways to unlock national science

Company demands urgent measures in face of new missed deadlines by the government and Anvisa and proposes experimental environment under judicial supervision

Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis: the three diseases treated with cannabis by the SUS in São Paulo

Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis: the three diseases treated with cannabis by the SUS in São Paulo

Special episode of Deusa Cast #46 brings together a team of industry pioneers for a precise diagnosis of the current state of cannabis in the country: a future that seems both inevitable and frustratingly distant. The debate points to misinformation as the true frontier to be overcome.

The historic initiative involves over 5,400 farmers, transforms the economy of the Rif region, and solidifies the country as a leader in the global regulated market

NuDeCann will have modular expansion in three phases until 2028, focusing on science, health, and sustainability

Scientists have identified over 50 compounds responsible for the distinct aromas of cannabis, revealing how terpenes and other molecules interact to create unique profiles